Education
About Us
Working with TipRanks
Follow Us
INVO Fertility (IVF)
NASDAQ:IVF
IVF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.03 - $51.08
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.99M
Market Cap
$4.58M
Enterprise Value$17.75M
Total Cash (Recent Filing)$549.18K
Total Debt (Recent Filing)$7.13M
Price to Earnings (P/E)―
Beta-0.39
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.53
Shares Outstanding4,363,016
10 Day Avg. Volume895,554
30 Day Avg. Volume2,994,409
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap3.87
Enterprise Value/Revenue2.68
Enterprise Value/Gross Profit7.00
Enterprise Value/Ebitda-0.74
Forecast
1Y Price Target
$1.50Price Target Upside33.93% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Business StrategyThe merger of INVO Biosciences with NAYA Biosciences creates a strong focus on developing a portfolio of bifunctional antibodies.
Market PositionNAYA Biosciences has the potential to become a significant player in first and second-line treatments for hepatocellular carcinoma by 2028.
Bears Say
Financial ChallengesRaising capital will likely take time in a particularly challenging market environment.
Regulatory ComplianceThe company received a letter from Nasdaq indicating that the company failed to file its 10-K on a timely basis and as such, no longer satisfies listing rules.
INVO Fertility News
IVF FAQ
What was INVO Fertility’s price range in the past 12 months?
INVO Fertility lowest stock price was $1.03 and its highest was $51.08 in the past 12 months.
What is INVO Fertility’s market cap?
INVO Fertility’s market cap is $4.58M.
When is INVO Fertility’s upcoming earnings report date?
INVO Fertility’s upcoming earnings report date is Aug 18, 2025 which is 5 days ago.
How were INVO Fertility’s earnings last quarter?
INVO Fertility released its earnings results on May 20, 2025. The company reported -$12.53 earnings per share for the quarter, missing the consensus estimate of N/A by -$12.53.
Is INVO Fertility overvalued?
According to Wall Street analysts INVO Fertility’s price is currently Undervalued.
Does INVO Fertility pay dividends?
INVO Fertility does not currently pay dividends.
What is INVO Fertility’s EPS estimate?
INVO Fertility’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Fertility have?
INVO Fertility has 4,363,016 shares outstanding.
What happened to INVO Fertility’s price movement after its last earnings report?
INVO Fertility reported an EPS of -$12.53 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.286%.
Which hedge fund is a major shareholder of INVO Fertility?
Currently, no hedge funds are holding shares in IVF
Company Description
INVO Fertility
INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fertility clinics, including “INVO Centers” offering the intravaginal culture (IVC) procedure enabled by its proprietary INVOcell® medical device. This device allows fertilization and early embryo development to occur in vivo within the woman’s body, providing a more natural, intimate, and affordable alternative to traditional IVF. INVO Fertility operates multiple centers in the U.S. and distributes the INVOcell technology to third-party clinics. The company separated its fertility and oncology businesses in April 2025 to focus exclusively on fertility care.
Technical Analysis
Helius Medical Technologies
―
Catheter Precision
―
Bone Biologics
―
Bluejay Diagnostics
―
Tivic Health Systems
―
Ownership Overview
―
Insiders
0.49% Mutual Funds
5.15% Other Institutional Investors
99.03% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---